Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International Journal of Cancer

• Publication date

  2016-03-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/ijc.29873PMID 26422827PMCID PMC4772139
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Notching on Cancer’s Door: Notch Signaling in Brain Tumors

  2015cited by this paper
• SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance

  2015cited by this paper
• Cancer stem cells in glioblastoma

  2015cited by this paper
• NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation.

  2015cited by this paper
• Gene Expression Mapping of Histone Deacetylases and Co-factors, and Correlation with Survival Time and 1H-HRMAS Metabolomic Profile in Human Gliomas

  2015cited by this paper
• Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment.

  2015cited by this paper
• Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

  2015cited by this paper
• Pharmacologic Wnt Inhibition Reduces Proliferation, Survival, and Clonogenicity of Glioblastoma Cells

  2015influential reference
• Notch signaling regulates adipose browning and energy metabolism

  2014cited by this paper
• Notch controls the survival of memory CD4+ T cells by regulating glucose uptake

  2014cited by this paper
• 1H NMR detects different metabolic profiles in glioblastoma stem‐like cells

  2014cited by this paper
• Mechanism by which a recently discovered allosteric inhibitor blocks glutamine metabolism in transformed cells

  2014cited by this paper
• Lactate and Choline Metabolites Detected In Vitro by Nuclear Magnetic Resonance Spectroscopy Are Potential Metabolic Biomarkers for PI3K Inhibition in Pediatric Glioblastoma

  2014cited by this paper
• Alteration of Mitochondrial Proteome Due to Activation of Notch1 Signaling Pathway*

  2014cited by this paper
• A High Notch Pathway Activation Predicts Response to γ Secretase Inhibitors in Proneural Subtype of Glioma Tumor‐Initiating Cells

  2014cited by this paper
• Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma

  2014cited by this paper
• A glioblastoma neurosphere line with alternative lengthening of telomeres

  2013cited by this paper
• Analysis of the genomic response of human prostate cancer cells to histone deacetylase inhibitors

  2013cited by this paper
• Clinical neurotransplantation protocol for Huntington's and Parkinson's disease

  2013cited by this paper
• Involvement of the Notch pathway in terminal astrocytic differentiation: role of PKA

  2013cited by this paper
• Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974

  2013cited by this paper
• Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy

  2012cited by this paper
• CD133/CD15 defines distinct cell subpopulations with differential in vitro clonogenic activity and stem cell-related gene expression profile in in vitro propagated glioblastoma multiforme-derived cell line with a PNET-like component.

  2012cited by this paper
• Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.

  2012cited by this paper
• Links between metabolism and cancer.

  2012cited by this paper
• 1H NMR Metabolomics Analysis of Glioblastoma Subtypes

  2012cited by this paper
• Wnt/beta-Catenin Signaling in Glioma

  2012cited by this paper
• Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation

  2012cited by this paper
• Mitochondrial localization and structure-based phosphate activation mechanism of Glutaminase C with implications for cancer metabolism

  2012cited by this paper
• 1H-Nuclear Magnetic Resonance Spectroscopy of Glioblastoma Cancer Stem Cells

  2011cited by this paper
• Glutamate and the biology of gliomas

  2011cited by this paper
• Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms

  2011cited by this paper
• The Notch Target Hes1 Directly Modulates Gli1 Expression and Hedgehog Signaling: A Potential Mechanism of Therapeutic Resistance

  2010cited by this paper
• Lentiviral Vectors to Probe and Manipulate the Wnt Signaling Pathway

  2010cited by this paper
• Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres.

  2010cited by this paper
• Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal

  2010cited by this paper
• Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

  2010cited by this paper
• Inhibition of glutaminase preferentially slows growth of glioma cells with mutant IDH1.

  2010cited by this paper
• c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• NOTCH Pathway Blockade Depletes CD133‐Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts

  2009influential reference
• Abstract #LB-186: c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism

  2009cited by this paper
• High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors

  2009cited by this paper
• Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.

  2008cited by this paper
• Notch signaling in development and cancer.

  2007cited by this paper
• Notch promotes survival of pre–T cells at the β-selection checkpoint by regulating cellular metabolism

  2005cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Histone deacetylase inhibitors.

  2005cited by this paper
• Notch signaling in development and disease

  2003cited by this paper
• Notch Signaling in Cancer

  2002cited by this paper
• In Vitro and in Vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells

  1994cited by this paper

• Energy metabolism in health and diseases

  2025cites this paper
• Metabolism of glioblastoma: a review of metabolic adaptations and metabolic therapeutic interventions

  2025cites this paper
• Amino acid metabolism in tumor biology and therapy

  2024cites this paper
• Comprehensive analysis based on glycolytic and glutaminolytic pathways signature for predicting prognosis and immunotherapy in ovarian cancer

  2024cites this paper
• Mechanism of Notch Signaling Pathway in Malignant Progression of Glioblastoma and Targeted Therapy

  2024cites this paper
• Role of Glycolytic and Glutamine Metabolism Reprogramming on the Proliferation, Invasion, and Apoptosis Resistance through Modulation of Signaling Pathways in Glioblastoma

  2023cites this paper
• Metabolism and signaling crosstalk in glioblastoma progression and therapy resistance

  2023cites this paper
• Glutamine Metabolism in Cancer Stem Cells: A Complex Liaison in the Tumor Microenvironment

  2023influential citation
• GLS2 is a tumor suppressor and a regulator of ferroptosis in hepatocellular carcinoma.

  2022cites this paper
• Noninvasive Pregestational Genetic Testing of Embryos Using Smart Sensors Array.

  2022cites this paper
• GLS2 is a tumor suppressor and a regulator of ferroptosis 1 in hepatocellular carcinoma

  2022influential citation
• Targeting Energy Metabolism in Cancer Treatment

  2022cites this paper
• Multiple strategies to improve the therapeutic efficacy of oncolytic herpes simplex virus in the treatment of glioblastoma.

  2021cites this paper
• Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery

  2021cites this paper
• Antioxidant responses related to temozolomide resistance in glioblastoma.

  2021cites this paper
• Glioblastoma Metabolomics—In Vitro Studies

  2021influential citation
• Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas

  2020cites this paper
• Targeting Glutamine Addiction in Gliomas

  2020cites this paper
• Metabolic Plasticity in Chemotherapy Resistance

  2020cites this paper
• A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity

  2020cites this paper
• A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma

  2020cites this paper
• Brain Tumor Stem Cell Dependence on Glutaminase Reveals a Metabolic Vulnerability through the Amino Acid Deprivation Response Pathway

  2020cites this paper
• Downregulation of Glutamine Synthetase, not glutaminolysis, is responsible for glutamine addiction in Notch1‐driven acute lymphoblastic leukemia

  2020cites this paper
• Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro

  2020cites this paper
• Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide

  2020cites this paper
• REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.

  2019cites this paper
• Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway

  2019cites this paper
• Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

  2019cites this paper
• Amino Acid-Mediated Metabolism: A New Power to Influence Properties of Stem Cells

  2019cites this paper
• Role of Notch Signaling Pathway in Glioblastoma Pathogenesis

  2019cites this paper
• Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer

  2018cites this paper
• Glutaminase inhibitors: a patent review

  2018cites this paper
• Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.

  2017cites this paper
• Inhibition of KGA / GAC : A Strategy for Exploiting Tumors ’ Glutamine Addiction

  2017cites this paper
• Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma

  2017cites this paper
• Glioblastoma and chemoresistance to alkylating agents: Involvement of apoptosis, autophagy, and unfolded protein response

  2017cites this paper
• Targeting cancer stem‐like cells in glioblastoma and colorectal cancer through metabolic pathways

  2017cites this paper
• Metabolic shift in density-dependent stem cell differentiation

  2017cites this paper
• CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells

  2017cites this paper
• Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells.

  2016cites this paper
• Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer.

  2016cites this paper